Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Antioxidants and Redox Signaling is Scopus-indexed (Q1, CiteScore 14.1), WoS SCIE. Published by SAGE Publications Ltd.
Checked against the index lists dated .
ISSN 1523-0864Verify ISSN ↗1557-7716Verify ISSN ↗
Publisher: SAGE Publications Ltd
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Clinical Biochemistry | 7 / 124 | 94th | Q1 |
| Physiology | 11 / 196 | 94th | Q1 |
| Biochemistry | 31 / 448 | 93rd | Q1 |
| Molecular Biology | 35 / 414 | 91st | Q1 |
| Cell Biology | 35 / 289 | 88th | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1999–present, best quartile Q1, CiteScore 14.1.
Antioxidants and Redox Signaling is Q1 in Clinical Biochemistry (rank 7 of 124), Q1 in Physiology (rank 11 of 196) and Q1 in Biochemistry (rank 31 of 448), by CiteScore 2025. It is ranked in 5 subject areas in all.
Antioxidants and Redox Signaling is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 14.1, which places it in quartile Q1 at the 94th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.820, quartile Q1, with an H-index of 252.
Antioxidants and Redox Signaling is published by SAGE Publications Ltd. Its print ISSN is 1523-0864 and its online ISSN is 1557-7716.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Antioxidants and Redox Signaling has an h-index of 273 and a 2-year mean of 5.48 citations per paper (OpenAlex). Its Scopus CiteScore is 14.1, quartile Q1. On 2-year citations it ranks #16 of 121 Scopus journals in Clinical Biochemistry.
Antioxidants and Redox Signaling published 79 papers in 2025; its busiest recent year was 2017 with 309. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2025–2026), authors are most often from China (80.5%), United States (4.3%) and Taiwan (2%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 20 retracted papers are recorded (3.8 per 1,000 papers). The Problematic Paper Screener flags 1 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.